Applied Therapeutics, a clinical-stage biopharmaceutical company, is under heightened scrutiny following the issuance of a November 2024 Warning Letter 1 from the US Food and Drug Administration ...
In the warning letter’s first observation, the FDA chided Viatris for failing to safeguard the reliability and integrity of its quality control data during component release testing. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback